Efficacy and Safety of ME3183 in Subjects With Moderate to Severe Plaque Psoriasis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The purpose of this study is to assess the efficacy and safety of ME3183 administered orally for moderate to severe plaque psoriasis in adults.
Epistemonikos ID: d881998d83a700c5ff0c028b15de0ee0cf296ab9
First added on: May 10, 2024